Please ensure Javascript is enabled for purposes of website accessibility

10 Growth Stocks to Combat Rising Interest Rates

Yesterday I revealed 10 value stocks to help combat rising interest rates. Today I have 10 growth stocks for your consideration.

In yesterday’s Wall Street’s Best Daily, I pointed out that interest rates are rising in the U.S. and will likely continue to rise during the next couple of years. To combat rising interest rates, I outlined a simple method of finding dividend-paying companies with minimal debt and strong balance sheets. Companies with these characteristics will likely perform very well if interest rates continue to climb.

How to Combat Rising Interest Rates

Today, I focus on companies with minimal debt and strong balance sheets that don’t pay a dividend. Finding companies that pay hefty dividends yielding 2.5% or more led me to slow-growing companies that are undervalued. Searching for companies that pay no dividends has a better chance of leading me to rapidly-expanding growth stocks. I am looking for companies that are plowing excess earnings and cash flow into research and development, marketing and expanded facilities.

To review: I set up a simple equation to measure the amount of debt. Benjamin Graham, considered the father of value investing, measured debt by dividing each company’s long-term debt by its current assets. Benjamin Graham’s formula was used in tandem with a separate formula that measured each company’s current assets divided by its current liabilities.

My next step is to screen all companies that do not pay dividends. That’s a very simple task and quickly changes the outcome of my search from value to growth. Undervalued companies tend to pay generous dividends, whereas growth stocks tend not to pay dividends.


My Growth Screening Criteria is summed up here:

  • Debt Burden (Long-Term Debt divided by Current Assets) = less than 5%.
  • Current Ratio (Current Assets divided by Current Liabilities) = greater than 2.00.
  • Dividend Yield = 0.0%.

The Results of this screen using my 1,000-stock Benjamin Graham database include the following 10 stocks:

10 Growth Stocks to Consider

Alphabet (GOOG) – Internet Software & Services

Cambrex (CBM) – Life Sciences Tools and Services

EPAM Systems (EPAM) – IT Consulting & Other Services

Facebook ((FB) – Internet Software & Services

ICU Medical (ICUI) – Health Care Supplies

Manhattan Associates (MANH) – Application Software

Monster Beverage (MNST) – Soft Drinks

National Beverage (FIZZ) – Soft Drinks

Ulta Beauty (ULTA) – Specialty Stores

United Therapeutics (UTHR) – Biotechnology

These companies are well qualified to withstand stock market disruptions caused by concerns over rising interest rates. Each company boasts a strong balance sheet with ample current assets to maintain future growth. These companies also apply their excess earnings to investing for the future growth.

Data screens are helpful, but the results only provide half the story. The future prospects of each company need to be examined before purchasing any of the stocks. I rely on research reports and each company’s website to form my opinion on whether the company’s future outlook is worthy of my purchase.

Why am I looking for growth stocks? Even as a value investor, I continue to recommend that you invest half of your portfolio in value stocks and half in growth stocks. The allocation can vary depending on your circumstances, but owning both value and growth stocks provides diversification, stability, income and growth.

Here’s the Deal.

I recently came up with a deal that’s tailor made for you. If you subscribe to my award-winning Cabot Benjamin Graham Value Investor, I will research any one of the 10 companies listed in today’s list of growth stocks or one of the 10 value dividend-paying stocks in yesterday’s list and send you my report. And here’s the best part: your report will be free, and you can subscribe to my Cabot Benjamin Graham Value Investor for the low price.

My performance record speaks for itself. Since inception on December 31, 1995, the Cabot Value Model has provided a return of 1,099% compared to a return of 701% for Warren Buffett’s Berkshire Hathaway (BRK-B). During the same 21-year period, the Dow gained just 307%. So don’t wait. Start your subscription today.


J. Royden Ward has spent his entire career seeking strong investment returns for his clients while keeping risk low. In 1969, he developed a computerized model of stock selection based on formulas created by investment legend—and Warren Buffett mentor—Benjamin Graham, and since 2003, he’s been spreading his wisdom far and wide as chief analyst of Cabot Benjamin Graham Value Investor.